Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Petersen

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Intercalating nucleic acids: the influence of linker length and intercalator type on their duplex stabilitiesUlf B Christensen, Michael Wamberg, Farag A G El-Essawy, et al.
Chronobiology International|August 4, 2025
Dynamic versus static LED-lighting for inpatients with major depression: Long-term antidepressant effects and short-term sleep improvement in a randomized controlled clinical trialCarlo Volf, Anne Sofie Aggestrup, Paul Michael Petersen, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trialMikkel Pejstrup Agger, Maibritt Horning, Marcus Schultz Carstensen, et al.
Chemical Communications (Cambridge, England)|May 14, 2015
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibitionStacey L Edwards, Vasanthanathan Poongavanam, Jagat R Kanwar, et al.
Annals of Medicine|May 20, 2024
Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX)Laura Sakalauskaitė, Luna S Hansen, Julie Margrethe Dubois, et al.
Pilot and Feasibility Studies|January 21, 2020
Dynamic LED light versus static LED light for depressed inpatients: results from a randomized feasibility trialCarlo Volf, Anne Sofie Aggestrup, Signe Dunker Svendsen, et al.
BMJ Open|January 29, 2020
Dynamic LED-light versus static LED-light for depressed inpatients: study protocol for a randomised clinical studyCarlo Volf, Anne Sofie Aggestrup, Paul Michael Petersen, et al.
Plos One|May 20, 2025
Re-evaluating the choice of gamma stimulation frequency for the potential treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma responses at various frequenciesMark Alexander Henney, Bianca Laura Hansen, Luna Skytte Hansen, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2023
Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot StudyMikkel Pejstrup Agger, Else Rubæk Danielsen, Marcus Schultz Carstensen, et al.
Human Genetics|August 7, 2007
Wolf-Hirschhorn syndrome-associated chromosome changes are not mediated by olfactory receptor gene clusters nor by inversion polymorphism on 4p16Marcella Zollino, Rosetta Lecce, Marina Murdolo, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
Intercalating nucleic acids: the influence of linker length and intercalator type on their duplex stabilitiesUlf B Christensen, Michael Wamberg, Farag A G El-Essawy, et al.
Chronobiology International|August 4, 2025
Dynamic versus static LED-lighting for inpatients with major depression: Long-term antidepressant effects and short-term sleep improvement in a randomized controlled clinical trialCarlo Volf, Anne Sofie Aggestrup, Paul Michael Petersen, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trialMikkel Pejstrup Agger, Maibritt Horning, Marcus Schultz Carstensen, et al.
Chemical Communications (Cambridge, England)|May 14, 2015
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibitionStacey L Edwards, Vasanthanathan Poongavanam, Jagat R Kanwar, et al.
Annals of Medicine|May 20, 2024
Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX)Laura Sakalauskaitė, Luna S Hansen, Julie Margrethe Dubois, et al.
Pilot and Feasibility Studies|January 21, 2020
Dynamic LED light versus static LED light for depressed inpatients: results from a randomized feasibility trialCarlo Volf, Anne Sofie Aggestrup, Signe Dunker Svendsen, et al.
BMJ Open|January 29, 2020
Dynamic LED-light versus static LED-light for depressed inpatients: study protocol for a randomised clinical studyCarlo Volf, Anne Sofie Aggestrup, Paul Michael Petersen, et al.
Plos One|May 20, 2025
Re-evaluating the choice of gamma stimulation frequency for the potential treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma responses at various frequenciesMark Alexander Henney, Bianca Laura Hansen, Luna Skytte Hansen, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2023
Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot StudyMikkel Pejstrup Agger, Else Rubæk Danielsen, Marcus Schultz Carstensen, et al.
Human Genetics|August 7, 2007
Wolf-Hirschhorn syndrome-associated chromosome changes are not mediated by olfactory receptor gene clusters nor by inversion polymorphism on 4p16Marcella Zollino, Rosetta Lecce, Marina Murdolo, et al.
Pageof 13